Shadi W. Hasan

Abstract The demand for rapid and scalable biosensing technologies has motivated the development of antibody-free platforms capable of operating in complex sample environments. Here, we report an electrochemical biosensor based on engineered M13 bacteriophages displaying a SARS-CoV-2 spike S1–binding peptide immobilized on a reduced graphene oxide (rGO) transducer.

Carbon dioxide valorization by catalytic hydrogenation using H2 from renewable sources is an attractive strategy for mitigating atmospheric emissions and reducing dependence on fossil fuels, but also to generate a variety of chemicals of commercial interest. However, the high chemical inertia of CO2 implies important energy barriers to overcome before it can participate in chemical reactions.